ABT’s all-oral HCV combo(s)The components will likely include ABT-450 (a PI), ABT-267 (an NS5A inhibitor), and one of the non-nukes (ABT-072 or ABT-333). In light of #msg-74608528 I will not be surprised if only 333 is moved to phase III.